Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors

References

• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657–86.
   PubMed Web of Science ®Google Scholar
• Li B, Li M, Qu L, Wang M, Guo J. Prevalence and characteristics of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from pediatric inpatients with respiratory tract infections at a teaching hospital in China. Scand J Infect Dis 2014;46:200–3.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165–74.
   PubMed Web of Science ®Google Scholar
• Jørgensen SB, Samuelsen Ø, Sundsfjord A, Bhatti SA, Jørgensen I, Sivapathasundaram T, et al. High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis. Scand J Infect Dis 2014;46:462–5.
   PubMed Web of Science ®Google Scholar
• Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalisation of CTX-M. Clin Microbiol Rev 2013;26:744–58.
   PubMed Web of Science ®Google Scholar
• Van Aken S, Lund N, Ahl J, Odenholt I, Tham J. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia. Scand J Infect Dis 2014;46:753–62.
   PubMed Web of Science ®Google Scholar
• Warren RE, Harvey G, Carr R, Ward D, Doroshenko A. Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community. Clin Microbiol Infect 2008;14(Suppl 1):S124–33.
   PubMedGoogle Scholar
• Lucet JC, Chevret S, Decré D, Vanjak D, Macrez A, Bédos JP, et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430–6.
   PubMed Web of Science ®Google Scholar
• Peña C, Pujol M, Ardanuy C, Ricart A, Pallares R, Liñares J, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:53–8.
   PubMed Web of Science ®Google Scholar
• Decré D, Gachot B, Lucet JC, Arlet G, Bergogne-Bérézin E, Régnier B. Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 1998;27:834–44.
   PubMedGoogle Scholar
• Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 2007;35:97–101.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62:1142–9.
   PubMed Web of Science ®Google Scholar
• Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Cantón R, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008;46:2796–9.
   PubMed Web of Science ®Google Scholar
• Löhr IH, Rettedal S, Natås OB, Naseer U, Oymar K, Sundsfjord A. Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother 2013;68:1043–8.
   PubMedGoogle Scholar
• Lo WU, Ho PL, Chow KH, Lai EL, Yeung F, Chiu SS. Fecal carriage of CTXM type extended-spectrum beta-lactamase-producing organisms by children and their household contacts. J Infect 2010;60:286–92.
   PubMedGoogle Scholar
• Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli. Scand J Infect Dis 2012;44:51–4.
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2008;46:1322–3.
   PubMed Web of Science ®Google Scholar
• Zahar JR, Lanternier F, Mechai F, Filley F, Taieb F, Mainot EL, et al. Duration of colonisation by Enterobacteriaceae producing extended-spectrum beta-lactamase and risk factors for persistent faecal carriage. J Hosp Infect 2010;75:76–8.
   PubMedGoogle Scholar
• Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC. Duration of colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae after hospital discharge. Am J Infect Control 2013;41:443–7.
   PubMed Web of Science ®Google Scholar
• Titelman E, Hasan CM, Iversen A, Nauclér P, Kais M, Kalin M, et al. Faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect 2014;20:O508–15.
   Google Scholar
• SKUOPZ. Antimicrobial resistance in Slovenia. Ljubljana: Institute of Microbiology and Immunology; 2014. Available from: http://www.imi.si/strokovna-zdruzenja/skuopz/skuopz (accessed 28 January 2015).
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing, 19th Informational Supplement. CLSI Document M100-S19. Clinical Laboratory Standards Institute; 2009.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing, 20th Informational Supplement. CLSI Document M100-S20. Clinical Laboratory Standards Institute; 2010.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing, 21st Informational Supplement. CLSI Document M100-S20. Clinical Laboratory Standards Institute; 2011.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing, 22nd Informational Supplement. CLSI Document M100-S22. Clinical Laboratory Standards Institute; 2012.
   Google Scholar
• Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20(Suppl 1):S1–55.
   PubMedGoogle Scholar
• Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect 2013;19:E190–6.
   PubMed Web of Science ®Google Scholar
• Cochard H, Aubier B, Quentin R, van der Mee-Marguet N. Extended-spectrum β-lactamase-producing Enterobacteriaceae in French nursing homes: an association between high carriage rate among residents, enviromental contamination, poor conformity with good hygiene practice, and putative resident-to-resident transmission. Infect Control Hosp Epidemiol 2014;35:384–9.
   PubMed Web of Science ®Google Scholar
• Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996;33:249–62.
   PubMedGoogle Scholar
• Cottell JL, Webber MA, Piddock LJV. Persistence of transferable extended-spectrum-β-lactamase resistance in the absence of antibiotic pressure. Antimicrob Agents Chemother 2012; 56:4703–6.
   PubMedGoogle Scholar
• Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 2000;3:303–11.
   PubMed Web of Science ®Google Scholar